RETRACTION: Cyclin-dependent kinase 7 (CDK7) is an emerging prognostic biomarker and therapeutic target in osteosarcoma (Retraction of Vol 13, art no 1759720X21995069, 2021)

被引:0
|
作者
Ma, H.
Dean, D. C.
Wei, R.
机构
关键词
D O I
10.1177/1759720X231188179
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:1
相关论文
共 5 条
  • [1] RETRACTED: Cyclin-dependent kinase 7 (CDK7) is an emerging prognostic biomarker and therapeutic target in osteosarcoma (Retracted article. See vol. 15, 2023)
    Ma, Hangzhan
    Dean, Dylan C.
    Wei, Ran
    Hornicek, Francis J.
    Duan, Zhenfeng
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2021, 13
  • [2] RETRACTION: Myc is a prognostic biomarker and potential therapeutic target in osteosarcoma (Retraction of Vol 12, art no 1758835920922055, 2020)
    Feng, W.
    Dean, D. C.
    Hornicek, F. J.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [3] Cyclin-dependent kinase 7 (CDK7) inhibitors as a novel therapeutic strategy for different molecular types of breast cancer
    Xue Song
    Chen Fang
    Yan Dai
    Yang Sun
    Chang Qiu
    Xiaojie Lin
    Rui Xu
    British Journal of Cancer, 2024, 130 : 1239 - 1248
  • [4] Cyclin-dependent kinase 9 (CDK9) is a novel prognostic marker and therapeutic target in osteosarcoma
    Ma, Hangzhan
    Seebacher, Nicole A.
    Hornicek, Francis J.
    Duan, Zhenfeng
    EBIOMEDICINE, 2019, 39 : 182 - 193
  • [5] Cyclin-dependent kinase 7 (CDK7) inhibitors as a novel therapeutic strategy for different molecular types of breast cancer
    Song, Xue
    Fang, Chen
    Dai, Yan
    Sun, Yang
    Qiu, Chang
    Lin, Xiaojie
    Xu, Rui
    BRITISH JOURNAL OF CANCER, 2024, 130 (08) : 1239 - 1248